Outcomes and Resource Utilization in Hyperkalemic Emergency Department Patients Treated With Patiromer or Sodium Zirconium Cyclosilicate
This large nationally representative sample of US ED patients showed that patiromer and SZC treatment had similar discharge dispositions to inpatient ward/home. Patients receiving patiromer had lower in-hospital mortality. Patients receiving SZC had lower 30-day all-cause and hyperkalemia-related hospitalization risks.
Authors
- James Neuenschwander
- Zubaid Rafique (ORCID: https://orcid.org/0000-0002-4176-5988)
- Ning Rosenthal (ORCID: https://orcid.org/0000-0002-3404-3717)
- W. Frank Peacock (ORCID: https://orcid.org/0000-0002-2730-6742)
- Jennifer Kammerer (ORCID: https://orcid.org/0000-0003-2699-9206)
- Harold Brown
- Jeffrey Budden
- Julie Gayle
Institutions
- Baylor College of Medicine (US)
- Doctors Hospital (US)
- Premier Research Group (US)
- Vifor Pharma (United States) (US)
Publication Details
- Journal
- Journal of the American College of Emergency Physicians Open
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1016/j.acepjo.2025.100158
- Citations
- 1
- Primary Topic
- Potassium and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.52